Mrs. Andreea-Liana Bot Rachisan, Romania
Novel biomarkers predictive for graft dysfunction – a pilot study using machine learning prediction as an AI tool
Dr. Huib De Jong, Netherlands
Is there a difference in outcome between DCD and DBD donor kidneys in pediatric transplant recipients? A nationwide analysis
Dr. Vikas Dharnidharka, United States
Contemporary treatment responses of recurrent focal segmental glomerulosclerosis or steroid resistant nephrotic syndrome in children after kidney transplantation: Phase 2 of a multicenter electronic health record data analysis
Dr. Ilja Finkelberg, Germany
Application of MC4R Agonist Setmelanotide in two post-renal transplant patients with Bardet-Biedl Syndrome (BBS): Successful Reduction in Hyperphagia and BMI
Nele Kanzelmeyer, Germany
Development of non-human leukocyte antigens antibodies and their association with antibody-mediated rejection in pediatric kidney transplant recipients
Dr. Lucy McAvoy, United Kingdom
Positive impact on graft function with repeated courses of Bortezomib in antibody-mediated rejection in a pediatric renal transplant recipient
Mrs. JoAnn M Morey, United States
Long term outcomes of sirolimus based immunosuppression among haplotyped-matched pediatric living donor kidney transplant recipients
Helen Pizzo, United States
Low incidence of rejection and de novo donor-specific antibody formation following covid-19 vaccination or infection among pediatric kidney transplant recipients
Dr. Moran Plonsky Toder, Israel
Phenotypic expansion of CRB2-related disease in monozygotic twins with multisystem involvement and severe post-transplant complications: Case report and literature review